Welcome to the Hope Bio Blog

How and why to enroll in FDA-authorized, DoD-backed research using Hope Bio's cells in TBI

Joined by University of Texas Health Science Center in Recruiting Participants HOUSTON, TX, October 16, 2019 – Hope Biosciences, a clinical stage biotechnology company focused on developing cell-based therapeutics for acute and chronic diseases, today announced that enrollment is now open for a Phase I/II trial evaluating safety and efficacy of Hope Biosciences’ autologous, adipose-derived mesenchymal stem cells (HB-adMSCs) for Traumatic Brain Injury and Hypoxic-Ischemic Ence